We are live on ! Find out more
ACUR

Acura Pharmaceuticals
ACUR

Delisted

ACUR was delisted on the 22nd of February, 2017.

Back to rankings

1 hedge funds and large institutions have $880K invested in Acura Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

20% less capital invested

Capital invested by funds: $1.1M → $880K (-$216K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ACUR Hedge Fund Activity: Q3 2017 in Review

1 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Acura Pharmaceuticals (ACUR) for Q3 2017, worth a combined $880K — down 20% from $1.1M a quarter earlier.

Fund positioning in ACUR was balanced in Q3 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Acura Pharmaceuticals (ACUR) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $880K of Acura Pharmaceuticals stock for Q3 2017, down 20% quarter-over-quarter.
  • 0 funds opened new Acura Pharmaceuticals positions in Q3 2017 and 0 closed out.

Based on aggregated 13F filings for Q3 2017.